Feasibility of imaging esophageal cancer with labeled somatostatin analogue (Q35049485)

6 August 2017

Feasibility of imaging esophageal cancer with labeled somatostatin analogue (English)

1 reference

6 August 2017

1 reference

Gunnar Herlin

1

1 reference

6 August 2017

Lars Ideström

2

1 reference

6 August 2017

Lars Lundell

3

1 reference

6 August 2017

Peter Aspelin

4

1 reference

6 August 2017

Rimma Axelsson

5

1 reference

6 August 2017

17 May 2011

1 reference

International journal of molecular imaging

6 August 2017

1 reference

6 August 2017

2011

1 reference

6 August 2017

279345

1 reference

Creative Commons Attribution 3.0 Unported

6 August 2017

start time

17 May 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116512

Endosonography: new developments

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116512

Multimodality assessment of esophageal cancer: preoperative staging and monitoring of response to therapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116512

Role of endoscopic ultrasound in superficial esophageal cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116512

Intraclass correlations: uses in assessing rater reliability

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116512

Incidence of carcinoma of the oesophagus and gastric cardia. Changes over time and geographical differences

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116512

The utility of 99mTc depreotide compared with F-18 fluorodeoxyglucose positron emission tomography and surgical staging in patients with suspected non-small cell lung cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116512

Somatostatin receptor imaging

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116512

Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical implications

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116512

Efficiency of 18F-FDG and 99mTc-depreotide SPECT in the diagnosis of malignancy of solitary pulmonary nodules

8 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F279345

99mTc-depreotide scintigraphy in the evaluation of indeterminate pulmonary lesions: clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F279345

Role of scintigraphy with technetium-99m depreotide in the diagnosis and management of patients with suspected lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F279345

Quantitative assessment of 99mTc-depreotide uptake in patients with non-small-cell lung cancer: immunohistochemical correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F279345

Dual-time-point F-18 FDG PET/CT for evaluation of intrathoracic lymph nodes in patients with non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F279345

Dual-phase F-18 FDG PET cannot increase the diagnostic accuracy to differentiate solitary pulmonary nodules

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F279345

Preoperative evaluation of hyperparathyroidism: the role of dual-phase parathyroid scintigraphy and ultrasound imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F279345

Dual-phase 18F-FDG PET in the diagnosis of pulmonary nodules with an initial standard uptake value less than 2.5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F279345

Quality of life in patients with gastroenteropancreatic tumors treated with [177Lu-DOTA0,Tyr3]octreotate

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F279345

68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F279345

Characterization of radiologically indeterminate lung lesions: 99mTc-depreotide SPECT versus 18F-FDG PET

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use

1 reference

12 December 2020

A multicenter trial with a somatostatin analog (99m)Tc depreotide in the evaluation of solitary pulmonary nodules

1 reference

12 December 2020

Somatostatin receptor subtype specificity and in vivo binding of a novel tumor tracer, 99mTc-P829

1 reference

12 December 2020

Identifiers

DOI

10.1155/2011/279345

1 reference

6 August 2017

1 reference

6 August 2017

1 reference